Article
Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving Subcutaneous IgG Infusions at Home
2022-09-21
Abstract excerpt
<title>Abstract</title> <p>Background and aims Subcutaneous immunoglobulin (SCIG) home infusion is widely used as an alternative to intravenous immunoglobulin (IVIG). The aim of this study is to determine the quality of life in primary immunodeficiency (PID) patient’s after switching to home based SCIG. Methods Prospective open-label, single center study. Quality of life (QoL) was determined using a validated...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 34ebbba5-98e6-5478-9b2e-d12e8c89f232
- DOI
- 10.21203/rs.3.rs-2018909/v1
